TETRAHYDROCANNALBINOL DIRECT BLOOD KIT

Radioimmunoassay, Cannabinoid(s)

Immunalysis Corporation

The following data is part of a premarket notification filed by Immunalysis Corporation with the FDA for Tetrahydrocannalbinol Direct Blood Kit.

Pre-market Notification Details

Device IDK791649
510k NumberK791649
Device Name:TETRAHYDROCANNALBINOL DIRECT BLOOD KIT
ClassificationRadioimmunoassay, Cannabinoid(s)
Applicant Immunalysis Corporation 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeLAT  
CFR Regulation Number862.3870 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1979-08-24
Decision Date1979-10-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.